Is Woodford Patient Capital Trust now a bargain or a value trap?

Neil Woodford’s Equity Income fund has been suspended, but the Woodford Patient Capital Trust (LON:WPCT) is open for business as usual. Read on if you’re thinking of buying.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Woodford Patient Capital Trust (LSE: WPCT) have lost more than 15% of their value since the troubles with manager Neil Woodford’s flagship Equity Income fund came to light on Tuesday. Could a similar problem to that afflicting the fund affect the investment trust?

There’s a key difference. With the Equity Income fund, investments have to be sold to give clients their money back, and the fund has a lot invested in illiquid and unquoted stocks, making that a bit tricky. And its liquid investments are already significantly diminished after the withdrawal of £560m in the past month or so.

Investment trust

That doesn’t happen with an investment trust, which is a closed-end fund and is immune to client selling. No cash is ever added to or withdrawn from it, and investors simply buy and sell shares in the fund instead. What happens if shareholders want to sell and run for the hills? If there are more sellers than buyers, the share price will simply fall in order to attract buyers.

But the underlying value of the fund remains the same, as its investments remain intact. Well, within reason, as a number of Patient Capital’s holdings have also dropped as part of the fallout. But generally, what happens when an investment trust’s shares fall in price is that you can buy them for less than the value of the underlying investments they represent.

Looking cheap?

Woodford Patient Capital Trust shares are now trading at a discount to the trust’s net asset value (NAV) of a shade under 25%. What that means is that you can buy the rights to £1-worth of investments (at current asset valuations) for approximately 75p. We have to bear in mind that investment trusts frequently trade at discounts to NAV, but rarely to this extent.

There are possible downsides. One of Woodford’s key points about this trust is that, in an innovative move, he doesn’t charge management fees. But there is increasing speculation that this approach will not be sustainable and that charges could be coming soon. Still, as several commentators have pointed out, at least shareholders haven’t had to pay for the poor performance of the trust since launch.

Putting aside the past week’s woes, Woodford Patient Capital shares have been underperforming for years. The trust share price remained ahead of the FTSE 100 for the first year or so, but since launch in 2015, the share price had fallen by more than 25% even before the latest shock revelation (compared to a 3% gain for the Footsie). After this week’s news, we’re looking at a 40% loss.

What do to?

With the current depressed mood, it’s possible there’s a bargain to be had here, but it’s all down to the actual value of the underlying assets. With quoted and liquid shares, that’s relatively easy to ascertain. But when it comes to unquoted firms, and illiquid and unprofitable start-ups, it’s hard to put any reliance on NAV as in many cases it’s a very subjective assessment.

My colleague G A Chester recently looked at this very problem, and I recommend reading his words before you think of buying Woodford Patient Capital shares.

Me? I don’t like hard-to-value investments, and I would never have invested in the first place.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Woodford Patient Capital. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »